COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,946 | -1.6% | 12,794 | -5.4% | 0.01% | +16.7% |
| Q2 2023 | $290,545 | -10.4% | 13,520 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $324,345 | +0.6% | 13,520 | -2.7% | 0.01% | -22.2% |
| Q4 2022 | $322,480 | +44.6% | 13,900 | 0.0% | 0.01% | -52.6% |
| Q3 2022 | $223,000 | -9.3% | 13,900 | 0.0% | 0.02% | +137.5% |
| Q2 2022 | $246,000 | -13.1% | 13,900 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $283,000 | +8.8% | 13,900 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $260,000 | -4.4% | 13,900 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $272,000 | – | 13,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |